Kati Patang Lifestyle Limited has scheduled an Extraordinary General Meeting (EGM) for Monday, April 06, 2026, at 3:00 PM IST through video conferencing to seek shareholder approval for strategic share swap arrangements worth Rs. 4.43 crore. The board of directors approved these transactions during their meeting held on March 12, 2026, involving the preferential issue of equity shares to acquire stakes in two private companies.

EGM Details and Voting Process

The company has provided electronic voting facilities for shareholders, with remote e-voting commencing on Friday, April 03, 2026, at 9:00 AM and ending on Sunday, April 05, 2026, at 5:00 PM. The record date for determining voting eligibility has been set as Monday, March 30, 2026.

Share Swap Arrangements Overview

The EGM will consider two special resolutions for strategic acquisitions through share swap arrangements. The transactions involve issuing 18,45,613 equity shares at Rs. 24 per share, determined in accordance with SEBI ICDR Regulations, 2018.

Strategic Acquisitions and Allottee Distribution

The first transaction involves acquiring 100% stake in Agnetta International Private Limited through the issuance of 14,58,333 equity shares to four proposed allottees. The major beneficiaries include Plumeria Hospital Pvt. Ltd. (4,65,572 shares), Komal Goyal (4,21,924 shares), and Puneet Ralhan (4,21,924 shares).

The second arrangement focuses on acquiring the remaining 2% stake in Empyrean Spirits Private Limited (ESPL) to make it a wholly-owned subsidiary. This involves issuing 3,87,280 equity shares to five shareholders, with Satish Krishnan receiving the largest allocation of 1,59,920 shares.

Shareholding Impact and Corporate Governance

Post-allotment, the combined shareholding of all proposed allottees will represent 4.27% of the company's total equity on a fully paid-up basis and 3.45% on a fully diluted basis. The company's post-issue share capital will comprise 4,31,78,893 equity shares of Rs. 10 each.

Regulatory Compliance and Next Steps

The preferential issue has been structured in compliance with Sections 23, 42, and 62 of the Companies Act, 2013, and Chapter V of SEBI ICDR Regulations. The relevant date for determining the minimum issue price was March 06, 2026, being 30 days prior to the EGM date. The company has obtained a certificate from practicing company secretary Saket Billa confirming compliance with SEBI ICDR Regulations.

The allotment must be completed within 15 days from the date of shareholder approval, subject to regulatory approvals. All equity shares will be issued in dematerialized form and will rank pari-passu with existing equity shares, including dividend and voting rights.

Kati Patang Lifestyle Limited has successfully completed the conversion of 54,35,000 warrants into equity shares on February 21, 2026, marking a significant milestone in the company's capital structure enhancement. The Board of Directors approved the allotment following the exercise of conversion rights by warrant holders, raising ₹4,07,62,500 through the process.

Warrant Conversion Details

The conversion involved 15 warrant holders across promoter and non-promoter categories, with each warrant converted into one equity share of face value ₹10. The exercise price was set at ₹7.50 per warrant, representing 75% of the total warrant price of ₹10 per warrant.

Major Allottees and Distribution

Among the significant allottees, Alt Attitude Advisory LLP received the largest allocation of 18,60,000 equity shares for ₹1,39,50,000. Shantanu Upadhyay was allotted 8,50,000 shares for ₹63,75,000, while Samrath Bedi from the promoter group received 7,50,000 shares for ₹56,25,000.

Impact on Share Capital

The warrant conversion has substantially increased the company's equity base. Post-allotment, the fully paid-up equity share capital expanded from 3,58,98,280 shares to 4,13,33,280 shares. The newly allotted equity shares rank pari-passu with existing fully paid equity shares, including dividend rights.

Warrant Issuance Background

The warrants were originally issued on August 22, 2024, following EGM approval granted on July 25, 2024. The total warrant issuance comprised 69,10,000 warrants, of which 14,75,000 warrants were previously converted on March 28, 2025. With the current conversion of 54,35,000 warrants, all outstanding warrants have been fully exercised, with no warrants remaining for future conversion.

Regulatory Compliance

The allotment was conducted in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has fulfilled all disclosure requirements and made the information available on its website. The Board meeting was held on February 21, 2026, from 4:00 PM to 5:00 PM IST, with Company Secretary Sanjeev K Jha overseeing the regulatory compliance process.